Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for

Yatrik M Shah1, Keiichirou Morimura, Qian Yang

  • 1National Cancer Institute, Bethesda, MD 20892, USA.

Insights

Peroxisome proliferator-activated receptor alpha (PPARalpha) activation drives liver cancer by inhibiting let-7C microRNA, which normally suppresses cell growth. This pathway is crucial for PPARalpha agonist-induced liver proliferation and tumorigenesis.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Oncology

Background:

  • Peroxisome proliferator-activated receptor alpha (PPARalpha) activation is linked to liver cancer development.
  • The precise early molecular events driving PPARalpha-mediated hepatocellular proliferation remain largely unknown.

Purpose of the Study:

  • To elucidate a novel mechanism by which PPARalpha regulates gene expression and hepatocellular proliferation.
  • To investigate the role of microRNAs (miRNAs) in PPARalpha-mediated liver oncogenesis.

Main Methods:

  • MicroRNA (miRNA) expression profiling in wild-type and Pparalpha-null mice treated with PPARalpha agonist Wy-14,643.
  • Analysis of let-7C targeting of c-myc and its downstream effects on the mir-17-92 cluster.
  • Validation in a human PPARalpha-expressing mouse model resistant to hepatocellular proliferation.

Main Results:

  • PPARalpha activation significantly altered hepatic miRNA expression, notably inhibiting let-7C.
  • let-7C directly targets c-myc, and its inhibition by PPARalpha leads to c-myc and mir-17-92 cluster upregulation.
  • In a humanized mouse model resistant to proliferation, Wy-14,643 did not inhibit let-7C or induce c-myc/mir-17, confirming let-7C's critical role.

Conclusions:

  • A let-7C signaling cascade is essential for PPARalpha agonist-induced liver proliferation and tumorigenesis.
  • PPARalpha agonists inhibit let-7C, leading to c-myc induction and subsequent oncogenic events.
  • Targeting the let-7C pathway may offer therapeutic strategies for PPARalpha-related liver diseases.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
Peroxisomes01:30

Peroxisomes

Peroxisomes and mitochondria are two important oxygen-utilizing organelles in eukaryotic cells. Mitochondria carry out cellular respiration—the process that converts energy from food into ATP. Peroxisomes carry out a variety of functions, primarily breaking down different substances, such as fatty acids.The peroxisome is a single membrane-bound cellular organelle that can perform several different functions, including lipid metabolism and chemical detoxification. The enzymes within peroxisomes...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...